Today's Daily Dose brings you news about Emergent BioSolutions' acquisition of privately-held Adapt Pharma; anticipated milestones of NuCana, and second quarter financial results of Tilray.Read on...Emergent BioSolutions Inc. (EBS) is all set to acquire Adapt Pharma and its flagship product NARCAN Nasal Spray for a total consideration of up to $735 million.NARCAN Nasal Spray is the first and only ...
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.